Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity
ClinicalTrials.gov study NCT02576288. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of recombinant human CD26/DPPIV protein or Sitagliptin (DPPIV enzyme inhibitor) on CD3 T cells at day 2 after in vitro cell culture
GEO Series GSE294787. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Data from: The effect of sitagliptin on carotid artery atherosclerosis in Type 2 Diabetes: the PROLOGUE randomized controlled trial
Open the record for dataset details and reuse information.
Gene expression alternations in the offspring rat intestine from sitagliptin-treated dams
GEO Series GSE134070. Rattus norvegicus. 6 samples. Type: Expression profiling by array.
Transcriptomic analysis reveals retinal neuromodulation by sitagliptin in an experimental model of diabetic retinopathy
GEO Series GSE219084. Mus musculus. 29 samples. Type: Expression profiling by array.
Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
ClinicalTrials.gov study NCT03122041. IPD Sharing: NO. Countries: 0. Publications: 0.
Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
ClinicalTrials.gov study NCT02675335. IPD Sharing: NO. Countries: 0. Publications: 0.
Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
ClinicalTrials.gov study NCT00832390. IPD Sharing: YES. Countries: 0. Publications: 0.
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01984606. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator
ClinicalTrials.gov study NCT06233201. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
ClinicalTrials.gov study NCT02900417. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
ClinicalTrials.gov study NCT02250794. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
ClinicalTrials.gov study NCT02941445. IPD Sharing: NO. Countries: 0. Publications: 0.
Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator
ClinicalTrials.gov study NCT06233240. IPD Sharing: NO. Countries: 0. Publications: 0.
Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes
ClinicalTrials.gov study NCT01824264. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
ClinicalTrials.gov study NCT02443922. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers
ClinicalTrials.gov study NCT02172196. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)
ClinicalTrials.gov study NCT00961480. IPD Sharing: Not stated. Countries: 0. Publications: 0.
DPP-4 inhibitor sitagliptin improves vascular endothelial function by modulating lncRNA and mRNA expression profiles in obese mouse aortae.
GEO Series GSE200814. Mus musculus. 9 samples. Type: Expression profiling by high throughput sequencing.
An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)
ClinicalTrials.gov study NCT00642798. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.